Compare CHRS & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHRS | SEVN |
|---|---|---|
| Founded | 2010 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.8M | 190.3M |
| IPO Year | 2014 | 2008 |
| Metric | CHRS | SEVN |
|---|---|---|
| Price | $1.52 | $8.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.51 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 839.0K | 97.7K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ 472.00 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | $73.08 | $27.75 |
| Revenue Next Year | $30.94 | $4.06 |
| P/E Ratio | ★ N/A | $44.32 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $7.90 |
| 52 Week High | $2.62 | $12.85 |
| Indicator | CHRS | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 54.01 |
| Support Level | $1.37 | $8.33 |
| Resistance Level | $1.75 | $8.83 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 67.31 | 57.19 |
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.